That's where Gossamer's new range of ultra-light packs aims to help - appropriately named as the Type 2 collection.

X-Men debuts the mutant hero who turned down Charles Xavier when he was assembling the team, revealing her mind-blowing superpower.

There’s a very specific thrill in swapping out your clunky old rucksack for a sleek, streamlined fastpack that seems to disappear once you put it on, and that’s exactly what Gossamer Gear ...

Previous rumors have claimed that the X-Men will face off against Mr. Sinister in Marvel Studios' reboot, but the evil geneticist may not be the only foe the mutants will encounter ...

Avengers: Doomsday will likely bid a final farewell to the original "X-Men Universe," and with a reboot looming, now may be a good time to revisit what didn't work about 20th Century Fox's mutant ...

Marvel reveals a first look at X-Men: Hellfire Vigil #1, featuring a celebration of their time on Krakoa and of the Hellfire Gala.

About Gossamer Bio Gossamer Bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension.

Gossamer Bio's seralutinib shows promise in PAH Phase 2 trials, but Phase 3 success is vital amidst competition. Click to read more on the risks and Hold rating insights.

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib fo ...

Gossamer’s management team will host a conference call and live audio webcast at 4:30 p.m. ET today, Thursday, May 15 th, to discuss its first quarter 2025 financial results and business update.

GOSSAMER BIO Hedge Fund Activity We have seen 43 institutional investors add shares of GOSSAMER BIO stock to their portfolio, and 47 decrease their positions in their most recent quarter.

Jesus Ricardo Patron Sanchez took over his Mexican drug cartel after his brother was killed — and is now facing the music alone after getting locked up in Brooklyn, federal prosecutors said.